nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefixime—Superinfection—Capecitabine—esophageal cancer	0.0799	0.0799	CcSEcCtD
Cefixime—Pruritus genital—Capecitabine—esophageal cancer	0.0434	0.0434	CcSEcCtD
Cefixime—Nephropathy toxic—Cisplatin—esophageal cancer	0.0429	0.0429	CcSEcCtD
Cefixime—Blister—Capecitabine—esophageal cancer	0.0252	0.0252	CcSEcCtD
Cefixime—Body temperature increased—Carboplatin—esophageal cancer	0.0237	0.0237	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.02	0.02	CcSEcCtD
Cefixime—Haemolytic anaemia—Cisplatin—esophageal cancer	0.0198	0.0198	CcSEcCtD
Cefixime—Renal failure acute—Cisplatin—esophageal cancer	0.0194	0.0194	CcSEcCtD
Cefixime—Blood bilirubin increased—Capecitabine—esophageal cancer	0.0192	0.0192	CcSEcCtD
Cefixime—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.0185	0.0185	CcSEcCtD
Cefixime—Colitis—Capecitabine—esophageal cancer	0.0174	0.0174	CcSEcCtD
Cefixime—Candida infection—Capecitabine—esophageal cancer	0.0173	0.0173	CcSEcCtD
Cefixime—Face oedema—Cisplatin—esophageal cancer	0.0173	0.0173	CcSEcCtD
Cefixime—Hepatic function abnormal—Capecitabine—esophageal cancer	0.0151	0.0151	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.0149	0.0149	CcSEcCtD
Cefixime—Pancytopenia—Cisplatin—esophageal cancer	0.0147	0.0147	CcSEcCtD
Cefixime—Haemolytic anaemia—Capecitabine—esophageal cancer	0.0146	0.0146	CcSEcCtD
Cefixime—Renal failure acute—Capecitabine—esophageal cancer	0.0143	0.0143	CcSEcCtD
Cefixime—Renal impairment—Capecitabine—esophageal cancer	0.0138	0.0138	CcSEcCtD
Cefixime—Dermatitis bullous—Capecitabine—esophageal cancer	0.0138	0.0138	CcSEcCtD
Cefixime—Renal failure—Cisplatin—esophageal cancer	0.0135	0.0135	CcSEcCtD
Cefixime—Vaginal inflammation—Methotrexate—esophageal cancer	0.0135	0.0135	CcSEcCtD
Cefixime—Vaginal infection—Methotrexate—esophageal cancer	0.0128	0.0128	CcSEcCtD
Cefixime—Face oedema—Capecitabine—esophageal cancer	0.0127	0.0127	CcSEcCtD
Cefixime—Aplastic anaemia—Methotrexate—esophageal cancer	0.0127	0.0127	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.0119	0.0119	CcSEcCtD
Cefixime—Pancytopenia—Capecitabine—esophageal cancer	0.0108	0.0108	CcSEcCtD
Cefixime—Neutropenia—Capecitabine—esophageal cancer	0.0106	0.0106	CcSEcCtD
Cefixime—Renal failure acute—Methotrexate—esophageal cancer	0.0106	0.0106	CcSEcCtD
Cefixime—Flatulence—Cisplatin—esophageal cancer	0.0106	0.0106	CcSEcCtD
Cefixime—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.0101	0.0101	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.0101	0.0101	CcSEcCtD
Cefixime—Renal failure—Capecitabine—esophageal cancer	0.00998	0.00998	CcSEcCtD
Cefixime—Jaundice—Capecitabine—esophageal cancer	0.0099	0.0099	CcSEcCtD
Cefixime—Urinary tract infection—Capecitabine—esophageal cancer	0.00987	0.00987	CcSEcCtD
Cefixime—Leukopenia—Cisplatin—esophageal cancer	0.00963	0.00963	CcSEcCtD
Cefixime—Agranulocytosis—Capecitabine—esophageal cancer	0.00947	0.00947	CcSEcCtD
Cefixime—Convulsion—Cisplatin—esophageal cancer	0.00932	0.00932	CcSEcCtD
Cefixime—Haemoglobin—Capecitabine—esophageal cancer	0.00916	0.00916	CcSEcCtD
Cefixime—Haemorrhage—Capecitabine—esophageal cancer	0.00911	0.00911	CcSEcCtD
Cefixime—Hepatitis—Capecitabine—esophageal cancer	0.00911	0.00911	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00883	0.00883	CcSEcCtD
Cefixime—Anaphylactic shock—Cisplatin—esophageal cancer	0.00878	0.00878	CcSEcCtD
Cefixime—Erythema multiforme—Capecitabine—esophageal cancer	0.00862	0.00862	CcSEcCtD
Cefixime—Thrombocytopenia—Cisplatin—esophageal cancer	0.0086	0.0086	CcSEcCtD
Cefixime—Eosinophilia—Methotrexate—esophageal cancer	0.00839	0.00839	CcSEcCtD
Cefixime—Pancytopenia—Methotrexate—esophageal cancer	0.00805	0.00805	CcSEcCtD
Cefixime—Neutropenia—Methotrexate—esophageal cancer	0.00793	0.00793	CcSEcCtD
Cefixime—Flatulence—Capecitabine—esophageal cancer	0.00782	0.00782	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00749	0.00749	CcSEcCtD
Cefixime—Renal failure—Methotrexate—esophageal cancer	0.00743	0.00743	CcSEcCtD
Cefixime—Leukopenia—Capecitabine—esophageal cancer	0.0071	0.0071	CcSEcCtD
Cefixime—Agranulocytosis—Methotrexate—esophageal cancer	0.00705	0.00705	CcSEcCtD
Cefixime—Body temperature increased—Cisplatin—esophageal cancer	0.00694	0.00694	CcSEcCtD
Cefixime—Haemoglobin—Methotrexate—esophageal cancer	0.00682	0.00682	CcSEcCtD
Cefixime—Haemorrhage—Methotrexate—esophageal cancer	0.00678	0.00678	CcSEcCtD
Cefixime—Hepatitis—Methotrexate—esophageal cancer	0.00678	0.00678	CcSEcCtD
Cefixime—Hypersensitivity—Cisplatin—esophageal cancer	0.00647	0.00647	CcSEcCtD
Cefixime—Erythema multiforme—Methotrexate—esophageal cancer	0.00641	0.00641	CcSEcCtD
Cefixime—Shock—Capecitabine—esophageal cancer	0.00637	0.00637	CcSEcCtD
Cefixime—Thrombocytopenia—Capecitabine—esophageal cancer	0.00634	0.00634	CcSEcCtD
Cefixime—Diarrhoea—Cisplatin—esophageal cancer	0.00601	0.00601	CcSEcCtD
Cefixime—Dyspepsia—Capecitabine—esophageal cancer	0.0057	0.0057	CcSEcCtD
Cefixime—Vomiting—Cisplatin—esophageal cancer	0.00558	0.00558	CcSEcCtD
Cefixime—Rash—Cisplatin—esophageal cancer	0.00554	0.00554	CcSEcCtD
Cefixime—Dermatitis—Cisplatin—esophageal cancer	0.00553	0.00553	CcSEcCtD
Cefixime—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00529	0.00529	CcSEcCtD
Cefixime—Leukopenia—Methotrexate—esophageal cancer	0.00529	0.00529	CcSEcCtD
Cefixime—Nausea—Cisplatin—esophageal cancer	0.00522	0.00522	CcSEcCtD
Cefixime—Urticaria—Capecitabine—esophageal cancer	0.00514	0.00514	CcSEcCtD
Cefixime—Body temperature increased—Capecitabine—esophageal cancer	0.00512	0.00512	CcSEcCtD
Cefixime—Abdominal pain—Capecitabine—esophageal cancer	0.00512	0.00512	CcSEcCtD
Cefixime—Convulsion—Methotrexate—esophageal cancer	0.00512	0.00512	CcSEcCtD
Cefixime—Anaphylactic shock—Methotrexate—esophageal cancer	0.00482	0.00482	CcSEcCtD
Cefixime—Hypersensitivity—Capecitabine—esophageal cancer	0.00477	0.00477	CcSEcCtD
Cefixime—Thrombocytopenia—Methotrexate—esophageal cancer	0.00472	0.00472	CcSEcCtD
Cefixime—Pruritus—Capecitabine—esophageal cancer	0.00458	0.00458	CcSEcCtD
Cefixime—Diarrhoea—Capecitabine—esophageal cancer	0.00443	0.00443	CcSEcCtD
Cefixime—Dizziness—Capecitabine—esophageal cancer	0.00428	0.00428	CcSEcCtD
Cefixime—Dyspepsia—Methotrexate—esophageal cancer	0.00424	0.00424	CcSEcCtD
Cefixime—Vomiting—Capecitabine—esophageal cancer	0.00412	0.00412	CcSEcCtD
Cefixime—Rash—Capecitabine—esophageal cancer	0.00408	0.00408	CcSEcCtD
Cefixime—Dermatitis—Capecitabine—esophageal cancer	0.00408	0.00408	CcSEcCtD
Cefixime—Headache—Capecitabine—esophageal cancer	0.00406	0.00406	CcSEcCtD
Cefixime—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00394	0.00394	CcSEcCtD
Cefixime—Nausea—Capecitabine—esophageal cancer	0.00385	0.00385	CcSEcCtD
Cefixime—Urticaria—Methotrexate—esophageal cancer	0.00383	0.00383	CcSEcCtD
Cefixime—Abdominal pain—Methotrexate—esophageal cancer	0.00381	0.00381	CcSEcCtD
Cefixime—Body temperature increased—Methotrexate—esophageal cancer	0.00381	0.00381	CcSEcCtD
Cefixime—Hypersensitivity—Methotrexate—esophageal cancer	0.00355	0.00355	CcSEcCtD
Cefixime—Pruritus—Methotrexate—esophageal cancer	0.00341	0.00341	CcSEcCtD
Cefixime—Diarrhoea—Methotrexate—esophageal cancer	0.0033	0.0033	CcSEcCtD
Cefixime—Dizziness—Methotrexate—esophageal cancer	0.00319	0.00319	CcSEcCtD
Cefixime—Vomiting—Methotrexate—esophageal cancer	0.00306	0.00306	CcSEcCtD
Cefixime—Rash—Methotrexate—esophageal cancer	0.00304	0.00304	CcSEcCtD
Cefixime—Dermatitis—Methotrexate—esophageal cancer	0.00304	0.00304	CcSEcCtD
Cefixime—Headache—Methotrexate—esophageal cancer	0.00302	0.00302	CcSEcCtD
Cefixime—Nausea—Methotrexate—esophageal cancer	0.00286	0.00286	CcSEcCtD
